Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Galinsky

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
JAMA Neurology|January 6, 2025
An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical TrialNiraj M Shanbhag, Jaya L Padmanabhan, Zheng Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2012
Sequence-based association and selection scans identify drug resistance loci in the Plasmodium falciparum malaria parasiteDaniel J Park, Amanda K Lukens, Daniel E Neafsey, et al.
Nature Genetics|August 7, 2012
The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparumDaniel E Neafsey, Kevin Galinsky, Rays H Y Jiang, et al.
Plos Neglected Tropical Diseases|March 18, 2015
Development of a single nucleotide polymorphism barcode to genotype Plasmodium vivax infectionsMary Lynn Baniecki, Aubrey L Faust, Stephen F Schaffner, et al.
Nucleic Acids Research|October 22, 2009
Pathema: a clade-specific bioinformatics resource center for pathogen researchLauren M Brinkac, Tanja Davidsen, Erin Beck, et al.
Science Translational Medicine|May 22, 2015
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogsJonathan D Herman, Lauren R Pepper, Joseph F Cortese, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
JAMA Neurology|January 6, 2025
An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical TrialNiraj M Shanbhag, Jaya L Padmanabhan, Zheng Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2012
Sequence-based association and selection scans identify drug resistance loci in the Plasmodium falciparum malaria parasiteDaniel J Park, Amanda K Lukens, Daniel E Neafsey, et al.
Nature Genetics|August 7, 2012
The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparumDaniel E Neafsey, Kevin Galinsky, Rays H Y Jiang, et al.
Plos Neglected Tropical Diseases|March 18, 2015
Development of a single nucleotide polymorphism barcode to genotype Plasmodium vivax infectionsMary Lynn Baniecki, Aubrey L Faust, Stephen F Schaffner, et al.
Nucleic Acids Research|October 22, 2009
Pathema: a clade-specific bioinformatics resource center for pathogen researchLauren M Brinkac, Tanja Davidsen, Erin Beck, et al.
Science Translational Medicine|May 22, 2015
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogsJonathan D Herman, Lauren R Pepper, Joseph F Cortese, et al.
Pageof 2